Letter to the Editor

Improving Risk Factors in Diabetic Patients Participating in a Weight Management Program

Authors: Byron Richard, MS, RD, CDE, Fanak Fahimi, PHARMD, BCPS, Nima Naderi, PHARMD, PHD

Abstract

Several studies have investigated the impact of weight loss in type 2 diabetic patients.1–3 Yet the role of different low-calorie diets and glucose control in obese diabetic patients has not been adequately studied.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1.Wilding J. Clinical evaluation of anti-obesity drugs. Curr Drug Targets 20045:325–332.
 
2.Shirai K. Obesity as the core of the metabolic syndrome and the management of coronary heart disease. Curr Med Res Opin 2004;20:295–304.
 
3.Kip KE, Marroquin OC, Kelley DE, et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women’s Ischemia Syndrome Evaluation (WISE) study. Circulation